The Biotech Council of New Jersey: 2003 Economic Impact Report

New Jersey attracts life science workers from across the nation with its access to culture, entertainment, economic and transportation centers like Philadelphia and New York City. With 124 biotechnology companies, New Jersey is now the fourth-largest biotechnology center in the nation. To assist in the development of this important industry cluster, the Biotechnology Council of New Jersey (BCNJ) was formed exclusively with representatives of biopharmaceutical, biomedical, bioagricultural and bioremedial enterprises.

Recognizing the importance of public information, the BCNJ engaged Deloitte, working together with Economic Development Research Group, to survey BCNJ members, document their economic activity in New Jersey, and identify the full range of impacts that the industry has on supporting jobs and income in the state. Results are available in the final report.

Full Report: The Biotech Council of NJ: 2003 Economic Impact Survey (pdf)

More Info on the Biotech Council of New Jersey

 

Latest Blogposts

Twitter Feed

Glen Weisbrod co-authored a chapter of the recently published book: Developing Bus Rapid Transit: The Value of BRT… https://t.co/cKLfFz0jt7
Transformational Change and the Future of Public Transportation. Blog by Glen Weisbrod https://t.co/TZNj2kUBDE #TRBAM
ROAD PRICING MAY BE COMING: ECONOMISTS ARE ON BOARD, BUT WILL THE PUBLIC BE CONVINCED?, blog by Kyle Schroeckenthal… https://t.co/2LmkCtAJtF
twitter 2 linkedin 2
 

Telephone: 1-617-338-6775 - This email address is being protected from spambots. You need JavaScript enabled to view it.

© 1997-2019 Economic Development Research Group, Inc; 155 Federal St. 6th Floor, Boston, MA 02110 USA